Not Tagged
Not Tagged
['nsclc', 'sclc']
#asco23
association of io duration with os in ansclc 2y fixed vs &gt;2y
2y os 79% vs 81% for patients who are progression-free on io for nsclc, it is reasonable to stop therapy at 2 years, rather than continuing indefinitely 
Medical Oncologist.                                            
        
On the trail of #SCIENCE to turn cancer into a manageable chronic disease. #bcsm #crcsm